IMMUNOHISTOCHEMICAL LOCALIZATION OF THE NEUROPEPTIDE, PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE (PACAP), IN HUMAN AND PRIMATE HYPOTHALAMUS

被引:123
|
作者
VIGH, S
ARIMURA, A
KOVES, K
SOMOGYVARIVIGH, A
SITTON, J
FERMIN, CD
机构
[1] TULANE UNIV,SCH MED,DEPT MED,NEW ORLEANS,LA 70112
[2] TULANE UNIV,SCH MED,DEPT ANAT,NEW ORLEANS,LA 70112
[3] TULANE UNIV,SCH MED,DEPT PHYSIOL,NEW ORLEANS,LA 70112
[4] TULANE UNIV,SCH MED,DEPT PATHOL,NEW ORLEANS,LA 70112
关键词
PACAP; IMMUNOHISTOCHEMISTRY; HUMAN AND PRIMATE HYPOTHALAMUS;
D O I
10.1016/0196-9781(91)90018-K
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A 38 residue neuropeptide was recently isolated from ovine hypothalamus in our laboratory, and named pituitary adenylate cyclase activating polypeptide (PACAP38) based on its biological activity. Rabbit antisera against synthetic PACAP27 were characterized by ELISA for immunohistochemical use. PACAP-immunoreactive neuronal elements having similar distributions were demonstrated in both human and spider monkey hypothalami. Many PACAP-immunoreactive cell bodies were present in the supraoptic and paraventricular nuclei. Immunopositive nerve fiber networks were stained throughout the hypothalamus, including in both external and internal zones of the tuber cinereum, close to the transition of the pituitary stalk (median eminence). These results suggest that PACAP plays multifunctional roles as a hypophysiotropic hormone, neurohypophysial hormone, neurotransmitter or neuromodulator in higher vertebrate species including man.
引用
收藏
页码:313 / 318
页数:6
相关论文
共 50 条
  • [1] STRUCTURE OF THE HUMAN PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE (PACAP) GENE
    HOSOYA, M
    KIMURA, C
    OGI, K
    OHKUBO, S
    MIYAMOTO, Y
    KUGOH, H
    SHIMIZU, M
    ONDA, H
    OSHIMURA, M
    ARIMURA, A
    FUJINO, M
    BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1129 (02) : 199 - 206
  • [2] GENE-EXPRESSION OF PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE (PACAP) IN THE RAT HYPOTHALAMUS
    HANNIBAL, J
    MIKKELSEN, JD
    CLAUSEN, H
    HOLST, JJ
    WULFF, BS
    FAHRENKRUG, J
    REGULATORY PEPTIDES, 1995, 55 (02) : 133 - 148
  • [3] OCULAR EFFECTS OF PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE (PACAP)
    NILSSON, SFE
    MAEPEA, O
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1992, 33 (04) : 1179 - 1179
  • [4] Tracing the Origins of the Pituitary Adenylate-Cyclase Activating Polypeptide (PACAP)
    Cardoso, Joao C. R.
    Garcia, Manuel G.
    Power, Deborah M.
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [5] CONCENTRATIONS OF PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE (PACAP) IN HUMAN BRAIN NUCLEI
    PALKOVITS, M
    SOMOGYVARIVIGH, A
    ARIMURA, A
    BRAIN RESEARCH, 1995, 699 (01) : 116 - 120
  • [6] CHARACTERIZATION OF OCULAR RECEPTORS FOR PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE (PACAP) AND THEIR COUPLING TO ADENYLATE-CYCLASE
    NILSSON, SFE
    DENEEF, P
    ROBBERECHT, P
    CHRISTOPHE, J
    EXPERIMENTAL EYE RESEARCH, 1994, 58 (04) : 459 - 467
  • [7] PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE (PACAP)-LIKE IMMUNOREACTIVITY IN HUMAN HYPOTHALAMUS - COLOCALIZATION WITH ARGININE-VASOPRESSIN
    TAKAHASHI, K
    TOTSUNE, K
    MURAKAMI, O
    SATOH, F
    SONE, M
    OHNEDA, M
    SASANO, H
    MOURI, T
    REGULATORY PEPTIDES, 1994, 50 (03) : 267 - 275
  • [8] PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE (PACAP)-LIKE IMMUNOREACTIVITY IN PHEOCHROMOCYTOMAS
    TAKAHASHI, K
    TOTSUNE, K
    MURAKAMI, O
    SONE, M
    ITOI, K
    MIURA, Y
    MOURI, T
    PEPTIDES, 1993, 14 (02) : 365 - 369
  • [9] VASCULAR EFFECTS OF PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE (PACAP) IN THE RABBIT
    NILSSON, SFE
    ACTA PHYSIOLOGICA SCANDINAVICA, 1991, 143 (01): : A13 - A13
  • [10] The role of pituitary adenylate-cyclase activating polypeptide (PACAP) in the trigeminovascular system
    Tuka, B.
    Helyes, Z.
    Markovics, A.
    Szoke, E.
    Bagoly, T.
    Reglodi, D.
    Kormos, V.
    Hashimoto, H.
    Tajti, J.
    Pardutz, A.
    Bohar, Z.
    Fejes, A.
    Szolcsanyi, J.
    Vecsei, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 240 - 240